Role of NKT Cells in the Pathogenesis of NAFLD

by Kazuto Tajiri, Yukihiro Shimizu
Published 2012-01-01

Vanishing Tumor in a Liver Graft from a Hepatitis B Virus Surface Antigen-Positive Donor

by Mayo Fuchino, Kazuto Tajiri, Masami Minemura, Toshiro Sugiyama
Published 2017-10-01

CD8 Positive T Lymphocyte Infiltration of Liver Metastases of Uveal Melanoma: A Case Report

by Naoki Takahashi, Kazuto Tajiri, Ko Kagoyana, Shinichi Tanaka, Ichiro Yasuda
Published 2021-06-01

A Case of Primary Biliary Cirrhosis That Progressed Rapidly after Treatment Involving Rituximab

by Kazuto Tajiri, Koichi Tsuneyama, Takahiro Miyazono, Kengo Kawai, Masami Minemura, Toshiro Sugiyama
Published 2013-04-01

Hyperbilirubinemia without Transaminitis during Combined Therapy with Daclatasvir and Asunaprevir

by Hayato Baba, Kazuto Tajiri, Kohei Nagata, Kengo Kawai, Masami Minemura, Toshiro Sugiyama
Published 2016-07-01

Successful Treatment with Crushed Sofosbuvir/Velpatasvir of a Patient with Decompensated Cirrhosis C and Thrombocytopenia

by Aiko Murayama, Kazuto Tajiri, Chiharu Kanegane, Jun Murakami, Yuka Hayashi, Ichiro Yasuda
Published 2021-08-01

Factors correlated with drug use for constipation: perspectives from the 2016 open Japanese National Database

by Hiroshi Mihara, Aiko Murayama, Sohachi Nanjo, Takayuki Ando, Kazuto Tajiri, Haruka Fujinami, Masaaki Yamada, Ichiro Yasuda
Published 2020-08-01

Management of Remnant or Recurrent Lesions after Endoscopic Papillectomy

by Ichiro Yasuda, Saito Kobayashi, Kosuke Takahashi, Sohachi Nanjo, Hiroshi Mihara, Shinya Kajiura, Takayuki Ando, Kazuto Tajiri, Haruka Fujinami
Published 2020-11-01

Intrahepatic Bile Duct Injury as a Hepatic Immune-Related Adverse Event after Immune-Checkpoint Inhibitor Treatment

by Aiko Murayama, Kazuto Tajiri, Atsuko Nakaya, Hiroyuki Ito, Yuka Hayashi, Toshiki Entani, Kohei Nagata, Shinichi Tanaka, Takeru Hamashima, Ichiro Yasuda
Published 2021-07-01

Perforation of the Small Intestine after Introduction of Lenvatinib in a Patient with Advanced Hepatocellular Carcinoma

by Naomi Suzuki, Kazuto Tajiri, Yuka Futsukaichi, Shinichi Tanaka, Aiko Murayama, Toshiki Entani, Saito Kobayashi, Kosuke Takahashi, Tsutomu Fujii, Johji Imura, Ichiro Yasuda
Published 2020-02-01

Diagnostic Fine-Needle Biopsy of Small Solid Pancreatic Lesions Using a Franseen Needle during Endoscopic Ultrasound Examination

by Kosuke Takahashi, Ichiro Yasuda, Tatsuyuki Hanaoka, Yuka Hayashi, Yasuhiro Araki, Iori Motoo, Shinya Kajiura, Takayuki Ando, Haruka Fujinami, Kazuto Tajiri, Masami Minemura, Terumi Takahara
Published 2021-12-01

Comparison of Histological Sample Volumes among Various Endoscopic Ultrasound-Guided Biopsy Needles

by Kosuke Takahashi, Ichiro Yasuda, Tatsuyuki Hanaoka, Yuka Hayashi, Iori Motoo, Shinya Kajiura, Takayuki Ando, Haruka Fujinami, Kazuto Tajiri, Johji Imura, Eisuke Ozawa, Satoshi Miuma, Hisamitsu Miyaaki, Kazuhiko Nakao
Published 2021-08-01

Validation of cross-genotype neutralization by hepatitis B virus-specific monoclonal antibodies by in vitro and in vivo infection.

by Susumu Hamada-Tsutsumi, Etsuko Iio, Tsunamasa Watanabe, Shuko Murakami, Masanori Isogawa, Sayuki Iijima, Takako Inoue, Kayoko Matsunami, Kazuto Tajiri, Tatsuhiko Ozawa, Hiroyuki Kishi, Atsushi Muraguchi, Takashi Joh, Yasuhito Tanaka
Published 2015-01-01

What Can Be Done to Solve the Unmet Clinical Need of Hepatocellular Carcinoma Patients following Lenvatinib Failure?

by Atsushi Hiraoka, Takashi Kumada, Toshifumi Tada, Kazuya Kariyama, Joji Tani, Shinya Fukunishi, Masanori Atsukawa, Masashi Hirooka, Kunihiko Tsuji, Toru Ishikawa, Koichi Takaguchi, Ei Itobayashi, Kazuto Tajiri, Noritomo Shimada, Hiroshi Shibata, Hironori Ochi, Kazuhito Kawata, Satoshi Yasuda, Hidenori Toyoda, Hideko Ohama, Kazuhiro Nouso, Akemi Tsutsui, Takuya Nagano, Norio Itokawa, Korenobu Hayama, Taeang Arai, Michitaka Imai, Yohei Koizumi, Shinichiro Nakamura, Kouji Joko, Kojiro Michitaka, Yoichi Hiasa, Masatoshi Kudo
Published 2021-02-01

Prognostic factor of lenvatinib for unresectable hepatocellular carcinoma in real‐world conditions—Multicenter analysis

by Atsushi Hiraoka, Takashi Kumada, Masanori Atsukawa, Masashi Hirooka, Kunihiko Tsuji, Toru Ishikawa, Koichi Takaguchi, Kazuya Kariyama, Ei Itobayashi, Kazuto Tajiri, Noritomo Shimada, Hiroshi Shibata, Hironori Ochi, Toshifumi Tada, Hidenori Toyoda, Kazuhiro Nouso, Akemi Tsutsui, Takuya Nagano, Norio Itokawa, Korenobu Hayama, Michitaka Imai, Kouji Joko, Yohei Koizumi, Yoichi Hiasa, Kojiro Michitaka, Masatoshi Kudo, the Real‐life Practice Experts for HCC (RELPEC) Study Group, HCC 48 Group (hepatocellular carcinoma experts from 48 clinics in Japan)
Published 2019-07-01

Impact of modified albumin–bilirubin grade on survival in patients with HCC who received lenvatinib

by Toshifumi Tada, Takashi Kumada, Atsushi Hiraoka, Masanori Atsukawa, Masashi Hirooka, Kunihiko Tsuji, Toru Ishikawa, Koichi Takaguchi, Kazuya Kariyama, Ei Itobayashi, Kazuto Tajiri, Noritomo Shimada, Hiroshi Shibata, Hironori Ochi, Satoshi Yasuda, Hidenori Toyoda, Shinya Fukunishi, Hideko Ohama, Kazuhito Kawata, Joji Tani, Shinichiro Nakamura, Kazuhiro Nouso, Akemi Tsutsui, Takuya Nagano, Tanaka Takaaki, Norio Itokawa, Tomomi Okubo, Taeang Arai, Michitaka Imai, Kouji Joko, Yohei Koizumi, Yoichi Hiasa, Real-life Practice Experts for HCC (RELPEC) Study Group and the HCC 48 Group (hepatocellular carcinoma experts from 48 clinics in Japan)
Published 2021-07-01

Efficacy of lenvatinib for unresectable hepatocellular carcinoma based on background liver disease etiology: multi-center retrospective study

by Atsushi Hiraoka, Takashi Kumada, Toshifumi Tada, Joji Tani, Kazuya Kariyama, Shinya Fukunishi, Masanori Atsukawa, Masashi Hirooka, Kunihiko Tsuji, Toru Ishikawa, Koichi Takaguchi, Ei Itobayashi, Kazuto Tajiri, Noritomo Shimada, Hiroshi Shibata, Hironori Ochi, Kazuhito Kawata, Satoshi Yasuda, Hidenori Toyoda, Tomoko Aoki, Takaaki Tanaka, Hideko Ohama, Kazuhiro Nouso, Akemi Tsutsui, Takuya Nagano, Norio Itokawa, Taeang Arai, Tomomi Okubo, Michitaka Imai, Yohei Koizumi, Shinichiro Nakamura, Koji Joko, Yoichi Hiasa, Masatoshi Kudo, The Real-life Practice Experts for HCC (RELPEC) Study Group and HCC 48 Group (hepatocellular carcinoma experts from 48 clinics in Japan)
Published 2021-08-01